These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1167 related articles for article (PubMed ID: 26163186)

  • 1. Morphological aspects of the hepatic response to neoadjuvant therapy.
    Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
    Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases.
    Serrablo A; Paliogiannis P; Pulighe F; Moro SS; Borrego-Estella V; Attene F; Scognamillo F; Hörndler C
    Eur J Surg Oncol; 2016 Sep; 42(9):1268-77. PubMed ID: 26947960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of tumor thickness at the tumor-normal interface in chemotherapy-treated hepatic colorectal metastasis.
    Abengózar M; Fernández-Aceñero MJ; Chaves S; Celdrán A
    Pathol Res Pract; 2012 Apr; 208(4):235-9. PubMed ID: 22444944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases.
    Maru DM; Kopetz S; Boonsirikamchai P; Agarwal A; Chun YS; Wang H; Abdalla EK; Kaur H; Charnsangavej C; Vauthey JN; Loyer EM
    Am J Surg Pathol; 2010 Sep; 34(9):1287-94. PubMed ID: 20697255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
    Cortés-Guiral D; Pastor-Iodate C; Díaz Del Arco C; Del Puerto-Nevado L; Fernández-Aceñero MJ
    Pathol Res Pract; 2017 Jun; 213(6):639-642. PubMed ID: 28551384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
    Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
    Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.
    Shia J; McManus M; Guillem JG; Leibold T; Zhou Q; Tang LH; Riedel ER; Weiser MR; Paty PB; Temple LK; Nash G; Kolosov K; Minsky BD; Wong WD; Klimstra DS
    Am J Surg Pathol; 2011 Jan; 35(1):127-34. PubMed ID: 21164296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hepatectomy margin on survival following resection of colorectal metastasis: the role of adjuvant therapy and its effects.
    Mbah NA; Scoggins C; McMasters K; Martin R
    Eur J Surg Oncol; 2013 Dec; 39(12):1394-9. PubMed ID: 24084087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma.
    Fernández-Aceñero MJ; Cortés D; Gómez del Pulgar T; Cebrián A; Estrada L; Martínez-Useros J; Celdrán A; García-Foncillas J; Pastor C
    Pathol Oncol Res; 2016 Apr; 22(2):377-83. PubMed ID: 26577686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
    Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases.
    Lucidi V; Hendlisz A; Van Laethem JL; Donckier V
    World J Gastroenterol; 2016 Apr; 22(15):3937-44. PubMed ID: 27099436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
    Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
    J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
    Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
    Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
    Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
    Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
    Ihnát P; Vávra P; Zonča P
    World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.